Established and emerging prognostic factors in mycosis fungoides and Sézary syndrome - Top-Institutions - MDSpire

Established and emerging prognostic factors in mycosis fungoides and Sézary syndrome

  • By

  • Viviane Liao

  • Robert N. Stuver

  • Shamir Geller

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Stanford Cutaneous Lymphoma Program
    Stanford Cutaneous Lymphoma Program

    Stanford, CA

    Key Differentiators

    • Dermatology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Dermatology

  • #3

    Northwestern University
    Northwestern University

    Chicago, IL

    Key Differentiators

    • Dermatology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Dermatology

Original Source(s)

Established and emerging prognostic factors in mycosis fungoides and Sézary syndrome

  • by Viviane Liao, Robert N. Stuver, Shamir Geller

  • July 1, 2026

Related Content

Therapeutic inhibition of RAS in non-small cell lung cancer

Metabolic sovereignty through oxidative hostility: a mechanistic perspective on how cancer engineers stromal dependency via ROS-mediated lysosomal reprogramming

Intralesional ALA-PDT for residual extramammary Paget's disease: a case report